During his campaign, US president Donald Trump vowed to ease the burden of the healthcare industry in US by reducing taxes and government regulations. Two important decisions expected from the Trump administration is appointment of Food and Drug Administration (FDA) commissioner and drug price control.
The industry players also want the government to provide a road map towards bringing down corporate income tax down to 25 percent.
The country "is one of the largest producers of pharmaceutical products and a leading player in the global generics market, exporting nearly 50 per cent of its production", according to the achievement report of the sector under the government's 'Make in India' initiative.
Increasing digitalisation, which reflects a transformation from marketing skills based on bags and brochures, and gender diversity are new catalysts for the pharmaceutical industry, according to speakers at a summit on human resources (HR) here.
Growth of the domestic pharmaceutical industry is likely to remain moderate due to factors like slowdown in the US market, increased competition and generic adoption reaching saturation levels, rating agency ICRA said today.
An India-Russia working group on industrial cooperation and modernisation during its meeting here identified fields such as technology for production of CRGO steel in India, modernisation of steel manufacturing facilities in India and pharmaceutical industry for enhancing cooperation.
Great companies build great legacies. Being a Torrentian is one such legacy that people who have worked long years at Torrent Pharma are proud of. This week on Skilltree Workplace Excellent we shed light on the work culture and the innovative practices at one of the leaders in the pharmaceutical Industry, Torrent Pharma.
Apart from concern about abuse of chemicals by drug mafia to manufacture psychotropic drugs, also known as party drugs, NCB officials are also worried about the sale of 'over the counter' medicines, which are used as drugs by many.
The Central Board of Excise and Customs (CBEC) has imposed definitive anti-dumping on import of Methyl Acetoacetate from the two countries for five years.
Government must not place the entire burden of access to healthcare on the pharmaceutical industry alone, Sanofi India has said while hitting out at more medicines being put under price control.
Investors in India's USD 15 billion pharmaceutical industry are favoring smaller firms with little or no exposure to the United States, where increasingly tight regulatory controls have burnt two of the country's biggest drugmakers over the past month.
Zota Healthcare Ltd. the fastest growing Indian Pharmaceutical group based in Surat bagged an award at the
The FDA's "import alert" comes two months after Canada banned the same site, citing data integrity issues. Europe also barred imports from the plant in early June citing critical deficiencies, including that staff deliberately did not record customer complaints.
As public spending on healthcare in India is among the lowest in the world, the increased public spending and sustainable financing mechanisms may improve access to healthcare in the country, Organisation of Pharmaceutical Producers of India (OPPI) said in a paper titled 'Healthcare Financing'.
The injectable drugs, known as PCSK9 inhibitors, could cost an estimated USD 7,000 to USD 12,000 per year for each person using the drug.
Government on Friday urged pharmaceutical companies to increase investment in research and development (R&D) to emerge as a hub of innovation in low cost health products and services.
CRISIL expects India‘s export revenues to grow by nearly 10-11 percent in 2015-16 to USD 28 billion, led by rising generic demand in regulated markets and India‘s cost-competitive product offerings.
A recent breakthrough by Zydus Cadilla, a family-owned drugmaker with annual revenues of USD 1 bn, reflects a new focus for leading Indian pharmaceutical groups: original drug research.
Indian pharmaceutical industry imports majority of active pharmaceutical ingredients (APIs) and intermediates worth billions of dollars from China.
India's pharmaceutical industry is on good growth trajectory and is likely to be among the top 10 global markets in value terms by 2020, according to a CII-PwC report released here today.
Swati Piramal, director of Piramal Healthcare tells CNBC-TV18 that it is one of the few pharma companies which are pushing for drug discovery.
India has promised not to link a proposed trade deal with the European Union with limiting its production of generic HIV/AIDS drugs, the United Nations said on Thursday, giving hope to millions of infected patients but underlining the hurdles for the controversial pact.
US doctors are too quick to reach for their prescription pads, according to a report urging them to think more about side effects and non-drug alternatives.
US Federal prosecutors are negotiating a settlement with Ranbaxy that could result in fines and payments exceeding USD 1 billion, as mentioned in the Fortune Magazine, for fraudulent conduct alleged by the FDA, reports CNBC-TV18's Ekta Batra.